FDA MedWatch - Risk of Exposure to Unsafe Levels of Radiation with Safe-T-Lite UV WAND:

FDA Safety Communication

If your email program has trouble displaying this email, view as a webpage. MedWatch - The FDA Safety Information and Adverse Event Reporting Program Risk of Exposure to Unsafe Levels of Radiation with Safe-T-Lite UV WAND: FDA Safety Communication Today, the U.S. Food and Drug Administration (FDA) issued a safety communication to warn consumers that use of the Max-Lux Safe-T-Lite UV WAND may expose the user or any nearby person to unsafe levels of ultraviolet-C (UV-C) radiation and may cause injury to the skin, eyes, or both after a few seconds of use. The FDA is aware that consumers may use the Max-Lux Safe-T-Lite UV WAND to try to disinfect surfaces and kill germs in the home or similar spaces. The FDA recommends that consumers consider using safer alternative disinfection methods, such as general purpose disinfectants. The FDA has issued a Notification of Defect Letter to Max-Lux Corporation Limited, providing notice that FDA had concluded, according to its regulations, that the Safe-T-Lite UV WAND has a defect. This safety communication provides: Important recommendations for consumers who are considering or have purchased the Max-Lux Safe-T-Lite UV WAND. Background on the issue and the FDA's actions to address the issue. Instructions for reporting problems with the Safe-T-Lite UV WAND to the FDA. Questions? If you have questions about this safety communication, contact the Division of Industry and Consumer Education DICE.   Read More

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA